Abstract:Purpose. Papillary renal cell carcinoma (pRCC) is the second most common histological subtype of adult kidney tumors, with a poor prognosis due to limited understanding of the disease mechanism. Herein, we have performed high-throughput bioinformatic screening to explore and identify potential biomarkers of DNA damage and oxidative stress for pRCC. Methods. RNA sequencing data related to pRCC were downloaded from the TCGA database, and differentially expressed genes (DEG) were identified by a wide variety of clustering and classification algorithms, including self-organized maps (SOM), artificial neural networks (ANN), support vector machines (SVM), fuzzy logic, and hyphenated techniques such as neuro-fuzzy networks. Then DAVID and STRING online biological information tools were used to analyze functional enrichment of the regulatory networks of DEG and construct a protein-protein interaction (PPI) network, and then the Cytoscape software was used to identify hub genes. The importance of key genes was assessed by the analysis of the Kaplan–Meier survival curves using the R software. Lastly, we have analyzed the expression of hub genes of DNA damage and oxidative stress (BDKRB1, NMUR2, PMCH, and SAA1) in pRCC tissues and adjacent normal tissues, as well as the relationship between the expression of hub genes in pRCC tissues and pathological characteristics and prognosis of pRCC patients. Results. A total of 1,992 DEGs for pRCC were identified, with 1,142 upregulated ones and 850 downregulated ones. The DEGs were significantly enriched in activities including DNA damage and oxidative stress, chemical synaptic transmission, an integral component of the membrane, calcium ion binding, and neuroactive ligand-receptor interaction. cytoHubba in the Cytoscape software was used to determine the top 10 hub genes in the PPI network as BDKRB2, NMUR2, NMU, BDKRB1, LPAR5, KNG1, LPAR3, SAA1, MCHR1, PMCH, and NCAPH. Furthermore, the expression level of hub genes BDKRB1, NMUR2, PMCH, and SAA1 in pRCC tissues was significantly higher than that in the adjacent normal tissues. Meanwhile, the expression level of hub genes BDKRB1, NMUR2, PMCH, and SAA1 in pRCC tissues was significantly positively correlated with tumor stage, lymph node metastasis, and the histopathology grade of pRCC. In addition, high expression levels of hub genes BDKRB1, NMUR2, PMCH, and SAA1 were associated with a poor prognosis for patients with pRCC. Univariate and multivariate analyses showed that the expression of hub genes BDKRB1, NMUR2, PMCH, and SAA1 were independent risk factors for the prognosis of patients with pRCC. Conclusion. The results of this analysis suggested that BDKRB1, NMUR2, PMCH, and SAA1 might be potential prognostic biomarkers and novel therapeutic targets for pRCC.

Screening and identification of key biomarkers of papillary renal cell carcinoma by bioinformatic analysis

Identification of Prognostic Markers of DNA Damage and Oxidative Stress in Diagnosing Papillary Renal Cell Carcinoma Based on High-Throughput Bioinformatics Screening

Genome-wide profiling identification of prognostic novel signatures in papillary renal cell carcinoma based on large-scale sequencing data

Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis

Integrated bioinformatics analysis for the identification of potential key genes affecting the pathogenesis of clear cell renal cell carcinoma

Bioinformatic Identification of Key Genes and Analysis of Prognostic Values in Clear Cell Renal Cell Carcinoma.

Screening, identification and validation of CCND1 and PECAM1/CD31 for predicting prognosis in renal cell carcinoma patients.

Identification of Key Genes and Prognostic Analysis between Chromophobe Renal Cell Carcinoma and Renal Oncocytoma by Bioinformatic Analysis

Novel molecular classification and prognosis of papillary renal cell carcinoma based on a large-scale CRISPR-Cas9 screening and machine learning

Screening and Identification of Novel Promoter Signatures in Clear Cell Renal Cell Carcinoma Metastasis.

Identification and Analysis of Novel Biomarkers Involved in Chromophobe Renal Cell Carcinoma by Integrated Bioinformatics Analyses

The Underlying Molecular Mechanism and Potential Drugs for Treatment in Papillary Renal Cell Carcinoma: A Study Based on TCGA and Cmap Datasets

Identification of Significant Genes with Prognostic Influence in Clear Cell Renal Cell Carcinoma Via Bioinformatics Analysis.

Identification of the key genes and pathways of human clear cell renal cell carcinoma by bioinformatics analysis

Identification of potential key genes and key pathways related to clear cell renal cell carcinoma through bioinformatics analysis

Bioinformatics and functional analyses of key genes and pathways in human clear cell renal cell carcinoma.

Identification of Key Genes and Pathways in Human Clear Cell Renal Cell Carcinoma (ccrcc) by Co-Expression Analysis

Identifying Biomarkers of Papillary Renal Cell Carcinoma Associated with Pathological Stage by Weighted Gene Co-Expression Network Analysis.

Identification of Potential Biomarkers for the Prognosis, Diagnosis, and Targeted Therapy in Kidney Renal Clear Cell Carcinoma

Identification of Potential Novel Differentially-Expressed Genes and Their Role in Invasion and Migration in Renal Cell Carcinoma.

Bioinformatics analysis and verification of gene targets for renal clear cell carcinoma